Vascular dementia (VaD) is the second common form of dementia and Chinese herbal medicine (CHM) has been used for aging-related disorders for thousands of years. However, there is still a lack of scientific evidence using CHM for VaD.
Objective:
To conduct a systematic review to assess the current evidence available for the effectiveness and safety of CHM for VaD.
Methods:
Six databases were searched for high-quality randomized-controlled clinical trials that met the requirements of at least 4 of the 7 domains of the Cochrane risk of bias tool from their inception to February 2017. RevMan 5.3 was applied for data analysis.
Results:
Forty studies with 42 comparisons and 3,572 individuals were included. The studies investigated the CHM versus placebo (n = 4), CHM versus western conventional treatment (WCT) (n = 36), and CHM plus WCT versus WCT (n = 2). Meta-analysis showed that CHM for VaD could improve Mini-Mental State Examination (MMSE), the Activities of Daily Living, Hasegawa’s dementia scale, and clinical effective rate but had statistically similar effect based on Blessed Behavior Scale (BBS) outcome when compared with WCTs. When compared with placebo, CHMs were more beneficial in improving MMSE but showed no significant difference in BBS scores. CHM as adjuvant therapy exerted an additive anti-VaD benefit on MMSE scores. The participants of CHM group had fewer adverse events than that of the placebo group or WCT group.
Conclusion:
The findings of the present study support, at least to an extent, that CHM can be recommended for routine use for treatment of VaD.
GorelickPB, ScuteriA, BlackSE, DecarliC, Greenberg, GreenbergSM, IadecolaC, LaunerLJ, LaurentS, LopezOL, NyenhuisD, PetersenRC, SchneiderJA, TzourioC, ArnettDK, BennettDA, ChuiHC, HigashidaRT, LindquistR, NilssonPM, RomanGC, SellkeFW, SeshadriS, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke42, 2672–2713.
2.
KalariaRN, MaestreGE, ArizagaR, FriedlandRP, GalaskoD, HallK, LuchsingerJA, OgunniyiA, PerryEK, PotocnikF, PrinceM, StewartR, WimoA, ZhangZX, AntuonoP, World Federation of Neurology Dementia Research Group (2008) Alzheimer’s disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol7, 812–826.
3.
RomanGC (2008) The Epidemiology of vascular dementia. Handb Clin Neurol89, 639–658.
4.
VenkatP, ChoppM, ChenJ (2015) Models and mechanisms of vascular dementia. Exp Neurol272, 97–108.
O’Brien, Markus (2014) Vascular risk factors and Alzheimer’s disease. BMC Med12, 218.
8.
MaurerK, VolkS, GerbaldoH (1997) Auguste D and Alzheimer’s disease. Lancet349, 1546–1549.
9.
BlessedG, TomlinsonBE, RothM (1968) The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry114, 797–811.
10.
HachinskiVC, LassenNA, MarshallJ (1974) Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet2, 207–210.
GorelickPB, ScuteriA, BlackSE, DecarliC, Greenberg, GreenbergSM, IadecolaC, LaunerLJ, LaurentS, LopezOL, NyenhuisD, PetersenRC, SchneiderJA, TzourioC, ArnettDK, BennettDA, ChuiHC, HigashidaRT, LindquistR, NilssonPM, RomanGC, SellkeFW, SeshadriS, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke42, 2672–2713.
13.
SachdevP, KalariaR, O’BrienJ, SkoogI, AlladiS, BlackSE, BlackerD, BlazerDG, ChenC, ChuiH, GanguliM, JellingerK, JesteDV, PasquierF, PaulsenJ, PrinsN, RockwoodK, RomanG, ScheltensP, International Society for Vascular Behavioral Cognitive Disorders (2014) Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis Assoc Disord28, 206–218.
14.
SkoogI (1998) Status of risk factors for vascular dementia. Neuroepidemiology17, 2–9.
ZhangHF, HuangLB, ZhongYB, ZhouQH, WangHL, ZhengGQ, LinY (2016) An overview of systematic reviews of Ginkgo biloba extracts for mild cognitive impairment and dementia. Front Aging Neurosci8, 276.
17.
VoisinT, LugardonS, BalardyL, VellasB (2003) Vascular risk factors and Alzheimer’s disease. Rev Med Interne24(Suppl 3), 288s–291s.
18.
de BruijnRF, IkramMA (2014) Cardiovascular risk factors and future risk of Alzheimer’s disease. BMC Med12, 130.
19.
AttemsJ, JellingerKA (2014) The overlap between vascular disease and Alzheimer’s disease–lessons from pathology. BMC Med12, 206.
20.
WellerRO, PrestonSD, SubashM, CarareRO (2009) Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther1, 6.
21.
ChangD, LiuJ, BilinskiK, XuL, SteinerGZ, SetoSW, BensoussanA (2016) Herbal medicine for the treatment of vascular dementia: An overview of scientific evidence. Evid Based Complement Alternat Med2016, 7293626.
QinXD, LiuY, WuYQ, WangS, WangDD, ZhuJQ, YeQF, MouW, KangLY (2013) A meta-analysis of Chinese herbal medicines for vascular dementia. Neural Regen Res8, 1685–1692.
25.
ZengLF, ZouYP, KongLS, WangNS, WangQ, WangL, CaoY, WangKZ, ChenYB, MiSQ, ZhaoW, WuHT, ChengSY, XuWH, LiangWX (2015) Can Chinese herbal medicine adjunctive therapy improve outcomes of senile vascular dementia? Systematic review with meta-analysis of clinical trials. Phytopher Res29, 1843–1857.
26.
ChanK, ShawD, SimmondsMS, LeonCJ, XuQ, LuA, SutherlandI, IgnatovaS, ZhuYP, VerpoorteR, WilliamsonEM, DuezP (2012) Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materiamedica. J Ethnopharmacol140, 469–475.
27.
HigginsJP, AltmanDG, GøtzschePC, JüniP, MoherD, OxmanAD, SavovicJ, SchulzKF, WeeksL, SterneJA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ343, d5928.
28.
ChungJH, LeeJW, JoJK, KimKS, LeeSW (2013) A quality analysis of randomized controlled trials about erectile dysfunction. World J Mens Health31, 157–162.
29.
LiHQ, WeiJJ, XiaW, LiJH, LiuAJ, YinSB, WangC, SongL, WangY, ZhengGQ, FanJP (2015) Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: A systematic review and meta-analysis. Acta Pharmacol Sin36, 659–675.
30.
RománGC, TatemichiTK, ErkinjunttiT, CummingsJL, MasdeuJC, GarciaJH, AmaducciL, OrgogozoJM, BrunA, HofmanA (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology43, 250–260.
31.
American Psychiatric Association (1980) American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-III, American Psychiatric Association, Washington, DC, USA.
32.
American Psychiatric Association (1994) American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, American Psychiatric Association, Washington, DC, USA.
33.
American Psychiatric Association (2000) American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR Fourth Edition, American Psychiatric Association, Washington, DC, USA.
34.
World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, World Health Organization, Geneva, Switzerland.
35.
FuRJ (1991) Traditional Chinese medicine differentiation and clinical effectiveness assessment in treating vascular dementia. J Tradit Chin Med32, 56.
36.
ZhengXY (2002) Clinical Research Guidelines of New Chinese Medicine for Curing Dementia.
37.
TianJZ, HanXM, TuJW, YangCZ, YangHM, LiJS, FuWM, ZhaoJJ, WangYY (2002) The scale differentiation of syndromes of vascular dementia. Chin J Gerontol22, 329–331.
38.
HigginsJP, SGreen (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0, The Cochrane Collaboration, http://handbook.cochrane.org/, Accessed March 2011.
39.
YangWT, ZhengXW, ChenS, ShanCS, XuQQ, ZhuJZ, BaoXY, LinY, ZhengGQ, WangY (2017) Chinese herbal medicine for Alzheimer’s disease: Clinical evidence and possible mechanism of neurogenesis. Biochem Pharmacol141, 143–155.
40.
CaiJ, DuJ, HuangJS, LinQC, ChenKY (2003) Effect of kangxin capsule on homocysteine and beta-amyloid protein in vascular dementia patients (in Chinese). Chin J Integr Med23, 664–667.
41.
LiaoXL, ChenKY, ZhengZR, LiuH, ZhengKY (2004) Clinical study of Shoulingjiannao capsule in improvement of brain function for patients with vascular dementia (in Chinese). Chin J Clin Rehab8, 112–114.
42.
LiuT, WangCH, YangJ, WuRZ, ShaoFY, YaoWL, XiaC (2005) Modified sanjiasan decoction in regulating intelligence state of patients with vascular dementia (in Chinese). Chin J Integr Med25, 492–495.
43.
XiaX, ShenXH, LiuYJ, TaiXF, DaiY, ZhangYB (2001) Clinical observation on effect of Baisuifang oral liquid in treating vascular dementia (in Chinese). Chin J Integr Med21, 569–572.
44.
ZhangY, WeiML, QiaoZL (2013) The haemodynamic effect of Bushen Yizhi decoction on senile vascular dementia (in Chinese). Guangming J Chin Med28, 1825–1827.
45.
PengW, DengHL (2007) The clinical study of promoting blood circulation for removing blood stasis and invigorating kidney for benefiting intelligence therapy on vascular dementia (in Chinese). J Changchun Univ Tradit Chin Med23, 29–30.
46.
XuXC, ZhangYM, ZhangH (2008) Clinical observation of Qingxin Huatan decoction in treatment of 36 cases of vascular dementia (in Chinese). Shanghai Tradit Chin Med42, 35–37.
47.
XuZH (2013) The clinical observation of the Nao Kang particle in the treatment of vascular dementia (blood stasis syndrome) (MD Thesis, in Chinese). http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CMFD&dbname=CMFD201402&filename=1013225413.nh&uid=WEEvREcwSlJHSldRa1FhcTdWZDluTmN6RnZMdVVhWC9ycG1KRUY1OXRCOD0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4ggI8Fm4gTkoUKaID8j8gFw!!&v=MDU3Mjg3RGgxVDNxVHJXTTFGckNVUkwyZmIrVnVGQ3ZuVnIzSlZGMjZIYkc2RzlYTnJKRWJQSVI4ZVgxTHV4WVM=, Accessed 31 August 2017.
48.
LiJY, HuangJS, ZhangZD, LinJ, ZhangWB, ZhengXM, LinQC (2009) Clinical study on Ruanmailing oral liquid in treatment of vascular dementia (in Chinese). Chin J Integr Med Cardio-/Cerebrovas Dis7, 1032–1034.
49.
YangYQ, ZhangZL, XueL, JiXQ, LiX, YangXJ (2016) The clinical study of Dingzhi Yicong granule in the influence of cognitive impairment on treatment of vascular dementia (in Chinese). Lishizhen Med Mathr Med Res27, 2196–2198.
50.
PuZP, FeiYE, LinY, XiaJM (2014) Treatment of vascular dementia patients with agitation of blood stagnation syndrome by oxcarbazepine and tongqiaohuoxue decoction separately: An efficacy comparison (in Chinese). Zhejiang J Integr Med24, 659–661.
51.
WangJS, LuoKX, LiHC, ChenFX, WangQX, ChenXL (2012) Curative effect study on treatment of vascular dementia with Shenmai capsule (in Chinese). China Moern Docter50, 94–95.
52.
TianJB, LiuXF, ZhaoJW, CuiY, YangLJ, QinD (2012) Observation of Qiangli Zengzhiling on the treatment of vascualr dementia (in Chinese). Herbei J TCM34, 17–19.
53.
ChenT, WuW (2016) Clinical observation on Jiannao Yifang combined with Western medicine in treating 30 cases of vascular dementia (in Chinese). J Tradit Chin Med57, 307–310.
54.
ChengWP, SuoQF, ZhangJ, MaL (2005) Naozhitong versus Naofuhuo in improvement of intelligence and plasma calcitonin-gene-related peptide of vascular dementia patients (in Chinese). Chin J Clin Reha9, 74–75.
55.
LiuX, DuJ, CaiJ, LiuX, XuG, LinA, TengQ (2007) Clinical systematic observation of Kangxin capsule curing vascular dementia of senile kidney deficiency and blood stagnation type. J Ethnopharmacol112, 350–355.
56.
TerasawaK, ShimadaY, KitaT, YamamotoT, TosaH, SaitoY, KanakiE, GotoS, MizushimaN, FujiokaM, TakaseS, SekiH, KimuraI, OgawaT, NakamuraS, ArakiG, MaruyamaI, MaruyamaY, TakaoriS (1997) Choto-san in the treatment of vascular dementia: A double-blind, placebo-controlled study. Phytomedicine4, 15–22.
57.
WuBB, ZhouDS, LiaoDF, GuoC, HuangY, DengL (2016) Clinical observation of Jianghuang-yizhi capsule on the treatment of vascular dementia (in Chinese). Heibei J TCM38, 1479–1483.
58.
TangN, HuYQ, WuL, WuYH, ZhangQ, HeQC, HuangQY (2014) Randomized and controlled clinical study on Yifei Xuanfei Jiangzhuo Capsule in the treatment of vascular dementia (in Chinese). Chin J Tradit Chin Med29, 3778–3781.
59.
YaoJS (2007) The clinical observation of Congzhi granules on treatment of vascular dementia (the syndrome of spleen and kidney deficiency amphi-stopping aperture by phlegm and blood stasis (MD Thesis, in Chinese). http://d.wanfangdata.com.cn/Thesis/Y1240194, Accessed 31 August 2017.
60.
SongSX (2002) The clinical study of Congsheng capsule on vascular dementia (MD Thesis, in Chinese). http://d.wanfangdata.com.cn/Thesis/Y465058, Accessed 31 August 2017.
61.
ZhangBL, WangYY, ChenRX, WangMH, GongT, ZhangYL, XieYZ, MaH (2002) Clinical randomized double-blinded study on treatment of vascular dementia by jiannaoyizhi granule (in Chinese). Chin J Integr Med22, 577–580.
62.
ZhuAH, TianJZ, ZhongJ, YangCZ, ShiJ, YinJX (2006) A clinical study on a randomized, double-blind control of Chinese medicine granules in treatment of vascular dementia (in Chinese). China J Chin Mater Med31, 1722–1725.
63.
DuGY, ZhuXC, ZhaoJJ, WangJ, TianJZ, LiuXF, ZhiHP, ZhaoY, CaoCC, CuiHF, WangXR, ZhangCY (2003) Clinical study of effect of Tianzhi granule on senile vascular dementia (in Chinese). China J Chin Mater Med28, 77–81.
64.
NiuQY (2009) The clinical observation of 42 cases of Tianzhi granule on vascular dementia (in Chinese). World Health Med Periodical8, 5–6.
65.
WangJ (2001) Clinical and experimental research on treatment of vascular dementia with Bushen Jiannao capsule (PhD Thesis, in Chinese). http://d.wanfangdata.com.cn/Thesis/Y400039, Accessed 31 August 2017.
66.
WangX (2006) Effect of Naimaitai capsule on vascular dementia: A randomized controlled trial and cost-effectiveness analysis (PhD Thesis, in Chinese). http://d.wanfangdata.com.cn/Thesis/Y868789, Accessed 31 August 2017.
67.
WangJP, TangN, GuL, MoSS, ZhouYY (2016) The clinical study on Yifei Xuanfei Jiangzhuo capsule in the treatment of mild-to-moderate vascular dementia (in Chinese). Guiding J TCM22, 71–73.
68.
WangQ (2007) The clinical research of Congzhi granule on treatment of vascular dementia (insufficience of kidney and spleen with turbid and gore toxin type) (MD Thesis, in Chinese). http://www.doc88.com/p-2156151522219.html, Accessed 31 August 2017.
ChengY (2001) Clinical and experimental study of tianmacuzhi granule on treatment of vascular dementia (MD Thesis, in Chinese). http://d.wanfangdata.com.cn/Thesis/Y404362, Accessed 31 August 2017.
71.
TongL (2004) The clinical study of Congsheng capsule on senile vascular dementia (PhD Thesis, in Chinese). http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CDFD&dbname=CDFD9908&filename=2004114098.nh&v=MDgxMTZQSVI4ZVgxTHV4WVM3RGgxVDNxVHJXTTFGckNVUkwyZmJ1WnVGeW5tVzdySVYxMjdHcks1R3RIRnA1RWI=, Accessed 31 August 2017.
72.
LuoZG, ZhouWQ, GaoP, CuiL (2001) Clinical study on treatment of senile vascular dementia with Shen Ma Yi Zhi capsule (in Chinese). J Tradit Chin Med42, 470–473.
73.
ZouYH, XieYZ, GaoY, MengFX, ZhangH, WangX (2001) Clinical observation of 30 cases of vascular dementia treated with congsheng capsules (in Chinese). J Beijing Univ TCM24, 54–57.
74.
GuoMD, ZhouWQ, WeiY, ZhaoCP (2010) Clinical curative effect of Shenxiong bushen capsule and its effection of the quality of life of patients with vascular dementia (in Chinese). Chin J Integr Med30, 593–597.
75.
ChenLP, WangFW, JiaJJ, HaoAZ (2007) Effects of Shenlong decoction on life quality of the aged patients with cerebral vascular dementia (in Chinese). Med J Chin PLA32, 866–868.
76.
WeiMQ, TianJZ, ShiJ, MaFY, MiaoYC, WangYY (2012) Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: A randomized, double-blind and parallel-controlled trial. J Chin Integr Med10, 1240–1246.
77.
FangX (2014) Effects of integrating Shuxue Tong injection and Edaravone injection on living quality in patients with vascular dementia after cerebral infarction with syndromes of stagnant blood obstructing collaterals (MD Thesis, in Chinese). http://d.wanfangdata.com.cn/Thesis/Y2607061, Accessed 31 August 2017.
78.
ZhaoZK, JiaFX, LiG, LiLZ, YangJH (2009) Clinical study on 51 patients with vascular dementia treated with Yizhicongming decoction (in Chinese). Heibei J TCM31, 493–496.
DeAngelisC, DrazenJM, FrizelleFA, HaugC, HoeyJ, HortonR, KotzinS, LaineC, MarusicA, OverbekeAJ, SchroederTV, SoxHC, Van Der WeydenMB, International Committee of Medical Journal Editors (2004) Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Med J Aust181, 293–294.
81.
KjaergardLL, VillumsenJ, GluudC (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med135, 982–989.
82.
European Medicines Agency/Committee for Medicinal Products for Human Use (EMA/CHMP) (2008) Guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias. CPMP/EWP/553/95 Rev. 1) 8.
83.
YuW, MaM, ChenX, MinJ, LiL, ZhengY, LiY, WangJ, WangQ (2017) Traditional Chinese medicine and constitutional medicine in China, Japan and Korea: A comparative study. Am J Chin Med45, 1–12.
84.
BensoussanA, TalleyNJ, HingM, MenziesR, GuoA, NguM (1998) Treatment of irritable bowel syndrome with Chinese herbal medicine: A randomized controlled trial. JAMA280, 1585–1589.
85.
TaichmanDB, BackusJ, BaethgeC, BauchnerH, de LeeuwPW, DrazenJM, FletcherJ, FrizelleFA, GrovesT, HaileamlakA, JamesA, LaineC, PeiperlL, PinborgA, SahniP, WuS (2016) Sharing clinical trial data: A proposal from the International Committee of Medical Journal Editors. Ann Intern Med164, 505–506.
86.
SchulzKF, AltmanDG, MoherD, CONSORT Group (2010) CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. Open Med4, e60–e68.
87.
BianZ, LiuB, MoherD, WuT, LiY, ShangH, ChengC (2011) Consolidated standardsof reporting trials (CONSORT) for traditional Chinese medicine: Current situationand future development. Front Med5, 171–177.
88.
FlowerA, WittC, LiuJP, Ulrich-MerzenichG, YuH, LewithG (2012) Guidelines for randomised controlled trials investigating Chinese herbal medicine. J Ethnopharmacol140, 550–554.
